Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study
-
Published:2023-04
Issue:
Volume:183
Page:98-108
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Wolf Jürgen,
Garon Edward B.ORCID,
Groen Harry J.M.ORCID,
Tan Daniel S.W.ORCID,
Gilloteau Isabelle,
Le Mouhaer Sylvie,
Hampe Marcio,
Cai Can,
Chassot-Agostinho Andrea,
Reynolds MariaORCID,
Sherif Bintu,
Heist Rebecca S.
Subject
Cancer Research,Oncology
Reference28 articles.
1. Module 1 Working Group. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007;Walters;Thorax,2013
2. Changing trends in diagnosis, staging, treatment and survival in lung cancer: comparison of three consecutive cohorts in an Australian lung cancer centre;Denton;Intern Med J,2016
3. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients;Barbera;Cancer,2010
4. Evolution of symptom burden of advanced lung cancer over a decade;Sung;Clin Lung Cancer,2017
5. Newly diagnosed patients with advanced non-small cell lung cancer: a clinical description of those with moderate to severe depressive symptoms;Andersen;Lung Cancer,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献